CLINICAL SUPPLY MANUFACTURING ARTICLES

Natural Killer Cell Receptor-GettyImages-1033017970 NK Cell Therapies: How Artiva Biotherapeutics Leverages Its "Manufacturing First" Approach

We caught up with Chris Horan, Artiva Biotherapeutics' CTO, to discuss natural killer cell therapies and Artiva’s experiences and strategies with its candidate, AlloNK.

CLINICAL SUPPLY MANUFACTURING VIDEOS

If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

CLINICAL SUPPLY MANUFACTURING RESOURCES